LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas (Q83357954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

9

Federico Garrido

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Isabel Maleno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jose Maria Romero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Laura Paco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Natalia Aptsiauri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jose Manuel Cozar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Miguel Tallada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Miguel Angel López-Nevot

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

17 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

503-510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705407%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00251-006-0111-8

21 January 2020

exact match

0 references

cites work

Cytokine regulation of expression of class I MHC antigens

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00251-006-0111-8

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00251-006-0111-8

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00251-006-0111-8

Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.

21 January 2018

1 reference

12 December 2020

MHC antigens and tumor escape from immune surveillance

1 reference

12 December 2020

Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization

1 reference

12 December 2020

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

1 reference

12 December 2020

Antigen presentation by MHC class I and its regulation by interferon gamma

1 reference

12 December 2020

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides

1 reference

12 December 2020

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

1 reference

12 December 2020

Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide

1 reference

12 December 2020

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

1 reference

12 December 2020

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

1 reference

12 December 2020

Criteria to define HLA haplotype loss in human solid tumors

1 reference

12 December 2020

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

12 December 2020

MHC class I antigens, immune surveillance, and tumor immune escape.

1 reference

12 December 2020

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

1 reference

12 December 2020

Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder

1 reference

12 December 2020

Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder

1 reference

12 December 2020

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

12 December 2020

Analysis of HLA-E expression in human tumors

1 reference

12 December 2020

Evidence for two bladder cancer suppressor loci on human chromosome 9

1 reference

12 December 2020

Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization

1 reference

12 December 2020

HLA class I expression in bladder carcinomas

1 reference

12 December 2020

Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival

1 reference

12 December 2020

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

12 December 2020

Altered MHC class I antigens in tumors.

1 reference

12 December 2020

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

1 reference

12 December 2020

High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss

1 reference

12 December 2020

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

1 reference

12 December 2020

Allelotype of human bladder cancer

1 reference

12 December 2020

Molecular genetic alterations in superficial and locally advanced human bladder cancer

1 reference

12 December 2020

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

1 reference

12 December 2020

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

12 December 2020